[HTML] springer.comFull View

[HTML][HTML] Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew, GJ Guillemin - Journal of …, 2020 - Springer
Background Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …
被引用次数：49 相关文章

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system …

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - search.proquest.com
Background Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - researchers.mq.edu.au
Background: Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …
[PDF] d-nb.info

[PDF][PDF] Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew, GJ Guillemin - 2020 - d-nb.info
Background: Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - europepmc.org
Background Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …
[HTML] nih.gov

[HTML][HTML] Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …

Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew… - Journal of …, 2020 - hero.epa.gov
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system
characterized by demyelination, neuroinflammation, and neurodegeneration. Activation of …
[PDF] archive.org

[PDF][PDF] Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression

G Sundaram, CK Lim, BJ Brew, GJ Guillemin - 2020 - scholar.archive.org
Background: Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central
nervous system characterized by demyelination, neuroinflammation, and …